Today, The New England Journal of Medicine. published results of stem cell transplants in infants with Severe Combined Immune Deficiency (SCID), noting the excellent survival among those diagnosed and treated early. This article resulted in national media coverage in The Wall Street Journal, CBS News, USA Today and several other sources that highlight the efficacy of SCID newborn screening.
The study, which examined transplant outcomes in infants with SCID from 2000-2009, serves as strong support for the IDF SCID Newborn Screening Campaign and the tireless efforts of many advocating for universal newborn screening for SCID. The study findings verify survival rates at 94% among infants receiving transplants at 3.5 months or younger.
The Wall Street Journal article “Study Adds Weight to Screening Newborns for Immune Disorder” included comments made by IDF regarding technical and financial barriers to screening for states causing difficulty for all states to implement screening as recommended by the Department of Health and Human Services in 2010.